What is the most recent earnings date for ANIK stock?
ANIKA THERAPEUTICS INC (ANIK) last reported earnings on 2/26/2026.
NASDAQ:ANIK • US0352551081
Past quarterly earnings results for ANIKA THERAPEUTICS INC (ANIK), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.02 | -0.22 | 109.12% | 101.33% | 30.615M | 29.453M | 3.95% | 0.04% |
| Q3 2025 | -0.16 | -0.28 | 41.90% | 36.00% | 27.817M | 28.356M | -1.90% | -28.22% |
| Q2 2025 | -0.28 | -0.26 | -8.36% | -2,700.00% | 28.219M | 27.574M | 2.34% | -32.69% |
| Q1 2025 | -0.34 | -0.15 | -132.56% | -9.68% | 26.168M | 28.628M | -8.59% | -35.42% |
| Q4 2024 | -1.50 | -0.30 | -398.50% | 65.12% | 30.602M | 29.58M | 3.46% | -28.78% |
| Q3 2024 | -0.25 | -0.02 | -1,533.99% | 44.44% | 38.753M | 42.924M | -9.72% | -6.54% |
| Q2 2024 | -0.01 | 0.05 | -121.01% | 94.74% | 41.921M | 42.941M | -2.38% | -5.37% |
| Q1 2024 | -0.31 | -0.19 | -62.81% | 34.04% | 40.523M | 39.926M | 1.50% | 6.85% |
| Q4 2023 | -4.30 | -0.27 | -1,500.91% | -1,164.71% | 42.971M | 42.233M | 1.75% | 8.46% |
| Q3 2023 | -0.45 | -0.38 | -18.17% | -200.00% | 41.465M | 39.031M | 6.24% | 2.99% |
| Q2 2023 | -0.19 | -0.28 | 31.01% | 5.00% | 44.302M | 41.368M | 7.09% | 11.70% |
| Q1 2023 | -0.47 | -0.31 | -53.59% | -135.00% | 37.924M | 38.026M | -0.27% | 3.36% |
| Q4 2022 | -0.34 | -0.24 | -38.89% | 15.00% | 39.62M | 38.459M | 3.02% | 10.61% |
| Q3 2022 | -0.15 | -0.26 | 41.18% | -475.00% | 40.26M | 38.337M | 5.02% | 1.82% |
| Q2 2022 | -0.20 | -0.23 | 13.50% | -144.44% | 39.66M | 38.609M | 2.72% | 3.96% |
| Q1 2022 | -0.20 | -0.37 | 46.28% | -200.00% | 36.69M | 33.557M | 9.34% | 7.00% |
| Q4 2021 | -0.40 | -0.26 | -55.31% | -433.33% | 35.82M | 32.693M | 9.56% | 9.57% |
| Q3 2021 | 0.04 | -0.21 | 118.67% | 108.89% | 39.54M | 37.044M | 6.74% | 24.77% |
| Q2 2021 | 0.45 | -0.15 | 400.80% | 221.62% | 38.15M | 35.196M | 8.39% | 24.35% |
| Q1 2021 | 0.20 | -0.13 | 256.86% | 233.33% | 34.29M | 32.841M | 4.41% | -3.14% |
| Q4 2020 | 0.12 | 0.14 | -15.97% | - | 32.69M | 34.17M | -4.33% | - |
| Q3 2020 | -0.45 | -0.01 | -4,311.76% | - | 31.69M | 30.716M | 3.17% | - |
| Q2 2020 | -0.37 | -0.25 | -48.06% | - | 30.68M | 20.775M | 47.68% | - |
| Q1 2020 | 0.06 | -0.07 | 190.50% | - | 35.4M | 32.163M | 10.06% | - |
Notes
ANIKA THERAPEUTICS INC (ANIK) last reported earnings on 2/26/2026.
ANIKA THERAPEUTICS INC (ANIK) beat EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, ANIKA THERAPEUTICS INC (ANIK) has beaten EPS estimates in 2 out of 4 releases.